Abstract
Ovarian hyperstimulation syndrome (OHSS) is a serious complication of controlled ovarian hyperstimulation which could be life-threatening. The present case is a patient at low risk for developing OHSS. She underwent a flexible antagonist protocol, followed by embryo transfer on day 3. She developed symptoms of abdominal pain, distension, and discomfort on the 7 th day after embryo transfer. She was diagnosed as moderate OHSS. Cabergoline 0.5 mg daily was started in addition to the standard treatment protocol for management of OHSS. On day 14 after embryo transfer, symptoms worsened following a positive pregnancy test. After this, cabergoline was stepped up to 1 mg/day. She was discharged, following complete resolution of her symptoms at 7 weeks of gestation. Cabergoline was withdrawn at discharge. Thus, in addition to the standard management protocol, prolonged high-dose cabergoline was required to help patient tide over OHSS and recover from it.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
